1 Min Read
Feb 6 (Reuters) - Halozyme Therapeutics Inc
* First Eagle Investment Management LLC reports a 5.94 percent passive stake in Halozyme Therapeutics Inc as of December 31, 2016 - SEC Filing Source text: [bit.ly/2kkBxab] Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.